När?onsdag 10 oktober 2018 ‑ fredag 12 oktober 2018
Paying special tribute to the rapid developments of informatics and bioengineering we selected and highlighted several topics that relate to these areas, such as multi-omics analysis, big-data-mining, predictive algorithms and medical robotics. We also want to address recently emerging technologies with potentially high impact for multiple sclerosis, including proteomics, deep sequencing, immunophenotyping and molecular imaging.
Because of the growing number and complexity of treatment options, the dialogue between “stakeholders” (neurologists, patients, health insurers, pharmaceutical industry) on the one side, and regulatory authorities on the other, is more important than ever. We have therefore added several topics with specific input from regulators, including a hot topic on “Biosimilars in multiple sclerosis” which impinges on world-wide access to immunomodulatory treatments.
As usual, the programme will offer teaching courses, plenary lectures, free communications selected from abstracts, as well as hot topic, young investigator and poster sessions.